News
More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.
Good news for activists after Trump administration disappointments. "For us to once again federalize the issue of abortion without a clear directive from Congress, right on the heels of Dobbs, would ...
A federal appeals court has ruled that West Virginia can limit access to mifepristone, a medication used to end early ...
A divided federal appeals court on Tuesday allowed West Virginia to restrict access to mifepristone, the pill used to end pregnancies that has emerged as a focal point of legal battles over abortion.
Both Students for Life and Liberty Counsel have claimed that mifepristone is contaminating public water systems, as well as rivers and streams, after remnants of the medication and pregnancy tissue ...
The ruling reverses the judge’s own decision from two years ago that allowed Washington state and 17 other states to continue ...
Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...
California, Massachusetts, New York and New Jersey petitioned the U.S. Food and Drug Administration on Thursday to ease its new restrictions on the abortion pill mifepristone, citing the drug's ...
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has ordered a fresh safety review of mifepristone, a drug commonly used in medication abortions.
Mifepristone is a widely used and government-approved abortion pill. While the new review has been requested, experts say the drug remains safe based on strong data from the last 20+ years.
Food and Drug Administration Commissioner Martin Makary confirmed in a Monday letter to the Missouri senator that the agency will conduct a safety review of the abortion pill mifepristone. Makary’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results